✦ LIBER ✦

ND1 COST-EFFECTIVENESS OF INTRATHECAL BACLOFEN THERAPY VERSUS CURRENT THERAPIES IN DISABLED SPASTICITY

✍ Scribed by A Beresniak; D Bensmail; A Ward; J Wissel; F Motta; L Saltuari; J Lissens; S Cros

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMD39 Cost Effectiveness Analysis of Int

✍ S. Malhan; E. Oksuz; Y. Ozsezer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Intrathecal baclofen therapy in children

✍ M A Hoving; S M A A Evers; A J H A Ament; E P M Van Raak; J S H Vles; On behalf 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Cost-effectiveness of Intrathecal Baclof

✍ de Lissovoy, G.; Matza, L. S.; Green, H.; Werner, M.; Edgar, T. 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 636 KB

TPC1: COST-EFFECTIVENESS ANALYSIS OF BUD

✍ A Szende; G Hoffer; K Kelenhegyi; E Cserhati; V Spicak 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Cost-Effectiveness of Sublingual Specifi

✍ Berto, P.; Canonica, G.W.; Crimi, N.; Frati, F.; Ortolani, C.; Passalacqua, G.; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 196 KB

PHM1 COST-EFFECTIVENESS OF ONCE-DAILY OR

✍ T Delea; O Sofrygin; S Thomas; JF Baladi; P Phatak; TD Coates 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB